Subsequent Events (Details) - P3 Health Partners Inc. - USD ($) |
1 Months Ended | 3 Months Ended | 6 Months Ended | 11 Months Ended | 12 Months Ended | ||||
|---|---|---|---|---|---|---|---|---|---|
May 18, 2022 |
Dec. 31, 2021 |
Jun. 30, 2022 |
Mar. 31, 2022 |
Jun. 30, 2022 |
Jun. 30, 2021 |
Dec. 02, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
| Subsequent Event [Line Items] | |||||||||
| Impairment charges | $ 0 | $ 851,455,754 | $ 0 | $ 851,455,754 | $ 0 | $ 0 | $ 0 | $ 0 | |
| Subsequent Event | |||||||||
| Subsequent Event [Line Items] | |||||||||
| Impairment charges | $ 851,500,000 | ||||||||
| Subsequent Event | Chief Executive Officer and Chief Medical Officer [Member] | |||||||||
| Subsequent Event [Line Items] | |||||||||
| Aggregate payments provided by bonus agreement | $ 10,000,000 | ||||||||
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Other employee benefit expense includes, but is not limited to, service component of net periodic benefit cost for defined benefit plan. Excludes compensation cost in cost of good and service sold. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|